2Lopez JJ, Carrasco JL. The importance of faster onset of antidepressant action. Medicographia, 2003, 25 : 42 -46.
3World Health Organization: Annual report. Metal health: new hopes,new perspectives. Geneva, Switzerland: WHO, 2001.
4Tylee A, Gaspar M, Lepine JP, et al. A patient survey of the symptoms, disability and current management of depression in the community. Int Clin Psychopharmacol, 1999, 114 : 139 - 151.
5Perez V, Gilaberie I, Faries D, et al. Randomised, double-blined,plcebo-controlled trim of pindolol incombination with fluoxetine antidepressant treatment. Lancet, 1997, 349 : 1594 - 1597.
6Haddjeri N, Blier P, De Montignic. Effect of the α2 adrenoceptor antagonist mirtazapine in the 5-HT system in the rat brain. J Pharmcol Exp ther, 1996, 277 : 861 -871.
7Leon AC. Measuring onset of antidepressant actionin clinical trials : an overview of definitions and methodology. J Clin Psychiatry, 2001,62(Suppl4) : 12-16.
8Leerubier Y. How do you define remissin? Aeta Psyehiatr Scand,2002, 106 (Supp1415) :7-11.
9World Health Organization: Annual report. Metal health: new hopes, new perspectives. Geneva, Switzerland: WHO, 2001
10Tylee A, Gaspar M, Lepine JP, et al. A patient survey of the symptoms, disability and current management of depression in the community. Int Clin Psychopharmacol, 1999, 114 : 139-151
